170 related articles for article (PubMed ID: 38383695)
1. Cryptogenic non-cirrhotic HCC: Clinical, prognostic and immunologic aspects of an emerging HCC etiology.
Beudeker BJB; Guha R; Stoyanova K; IJzermans JNM; de Man RA; Sprengers D; Boonstra A
Sci Rep; 2024 Feb; 14(1):4302. PubMed ID: 38383695
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H
Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446
[TBL] [Abstract][Full Text] [Related]
4. The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis.
Tobari M; Hashimoto E; Taniai M; Kodama K; Kogiso T; Tokushige K; Yamamoto M; Takayoshi N; Satoshi K; Tatsuo A
J Gastroenterol Hepatol; 2020 May; 35(5):862-869. PubMed ID: 31597206
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.
Leung C; Yeoh SW; Patrick D; Ket S; Marion K; Gow P; Angus PW
World J Gastroenterol; 2015 Jan; 21(4):1189-96. PubMed ID: 25632192
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease.
Seif El Dahan K; Daher D; Singal AG
Clin Mol Hepatol; 2023 Feb; 29(Suppl):S207-S219. PubMed ID: 36103899
[TBL] [Abstract][Full Text] [Related]
7. Is mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis.
Nakanuma Y; Ohta G
Cancer; 1985 May; 55(10):2400-4. PubMed ID: 2985233
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma.
Lee SS; Jeong SH; Byoun YS; Chung SM; Seong MH; Sohn HR; Min BY; Jang ES; Kim JW; Park GJ; Lee YJ; Lee KH; Ahn S
BMC Cancer; 2013 Jul; 13():335. PubMed ID: 23829392
[TBL] [Abstract][Full Text] [Related]
9. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in the non-cirrhotic liver.
Dong Y; Wang WP; Lee WJ; Meloni MF; Clevert DA; Chammas MC; Tannapfel A; Forgione A; Piscaglia F; Dietrich CF
Clin Hemorheol Microcirc; 2022; 80(4):423-436. PubMed ID: 34842182
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
Pinyopornpanish K; Al-Yaman W; Dasarathy S; Romero-Marrero C; McCullough A
Dig Dis Sci; 2022 Jun; 67(6):2677-2687. PubMed ID: 34027591
[TBL] [Abstract][Full Text] [Related]
12. A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis: HCC prediction for non-cirrhotic NAFLD.
Kim GA; Park Y; Oh SJ; Jung J; Han S; Chang HS; Park SW; Kim TH; Park HW; Choe J; Kim J; Lee HC
Liver Int; 2024 Mar; 44(3):738-748. PubMed ID: 38110797
[TBL] [Abstract][Full Text] [Related]
13. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH
Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023
[TBL] [Abstract][Full Text] [Related]
14. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.
Donati B; Dongiovanni P; Romeo S; Meroni M; McCain M; Miele L; Petta S; Maier S; Rosso C; De Luca L; Vanni E; Grimaudo S; Romagnoli R; Colli F; Ferri F; Mancina RM; Iruzubieta P; Craxi A; Fracanzani AL; Grieco A; Corradini SG; Aghemo A; Colombo M; Soardo G; Bugianesi E; Reeves H; Anstee QM; Fargion S; Valenti L
Sci Rep; 2017 Jul; 7(1):4492. PubMed ID: 28674415
[TBL] [Abstract][Full Text] [Related]
15. Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study.
Prabhakar T; Kaushal K; Prasad M; Gupta E; Sood A; Jain AK; Shukla A; Goel A; Duseja A; Saraya A; Shah S; Kumar G; Sarin SK
Hepatol Int; 2023 Jun; 17(3):745-752. PubMed ID: 36940070
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
Wong CR; Nguyen MH; Lim JK
World J Gastroenterol; 2016 Oct; 22(37):8294-8303. PubMed ID: 27729736
[TBL] [Abstract][Full Text] [Related]
17. Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.
Pal Chaudhary S; Reyes S; Chase ML; Govindan A; Zhao L; Luther J; Bhan I; Bethea E; Franses JW; Paige Walsh E; Anne Dageford L; Kimura S; Elias N; Yeh H; Markman J; Bozorgzadeh A; Tanabe K; Ferrone C; Zhu AX; Andersson K; Thiim M; Antonio Catalano O; Kambadakone A; Vagefi PA; Qadan M; Pratt D; Hashemi N; Corey KE; Misdraji J; Goyal L; Clark JW
Oncologist; 2023 Apr; 28(4):341-350. PubMed ID: 36763374
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease.
Tovoli F; Ferri S; Piscaglia F
Curr Pharm Des; 2020; 26(32):3909-3914. PubMed ID: 32348210
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
Liew ZH; Goh GB; Hao Y; Chang PE; Tan CK
Dig Dis Sci; 2019 Feb; 64(2):585-590. PubMed ID: 30327962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
